Mitzi Chang, a partner in Goodwin’s Technology Companies & Life Sciences Group, focuses her practice on corporate and securities law, representing public and private companies, venture capital and private equity firms and investment banks in capital markets transactions, mergers and acquisitions, venture capital financings, SEC reporting and other general corporate and securities matters. Ms. Chang advises companies through every stage of the corporate life cycle – from initial financing through successful initial public offering or acquisition. Ms. Chang also spent three years as in-house legal counsel at a Nasdaq-listed public technology company in San Francisco. Ms. Chang has substantial intellectual property transactional experience within the digital media, online services, advertising and entertainment space.

In addition, Ms. Chang is a member of the firm’s Impact and Responsible Investment (IRI) practice. She currently serves on the firm’s Committee on Racial and Ethnic Diversity and is on the hiring committee for Goodwin’s San Francisco office.




Work for clients:

Public offerings

  • aTyr Pharma, Inc. in its $75 million initial public offering and $35 million at-the-market offering
  • Fate Therapeutics, Inc. in its $40 million initial public offering, $30 million follow-on public offering, $8 million private placement with Juno Therapeutics and PIPE transactions totaling $67 million
  • Imperva in its $90 million initial public offering
  • Various underwriters in connection with a $43 million follow-on offering for Regulus Therapeutics
  • Anthera Pharmaceuticals, Inc. in its $42 million initial public offering and $31.5 million PIPE transaction
  • A biopharmaceutical company in its $9 million follow-on public offering
  • A nanotechnology holding company in its $8 million registered direct offering

Mergers and acquisitions

  • Teva Pharmaceuticals Industries, Ltd. in its $3.2 billion acquisition of Auspex Pharmaceuticals, Inc.
  • ECG Management Consultants, Inc. in its recapitalization by Gryphon Investors
  • Spotlite, Inc. in its sale to Rally Health
  • Onyx Pharmaceuticals, Inc. in its $10.4 billion sale to Amgen
  • Courier Corporation in its acquisition of FastPencil, Inc.
  • Location Labs in its sale to AVG Technologies
  • InsightsOne Systems, Inc. in its sale to Apigee Corporation
  • A startup company in a “spin-in” transaction with a publicly traded technology company
  • Companies in acquihire transactions with Facebook, Google, Yahoo!, and Ebay
  • Whiskey Media in its sale transactions with CBS Interactive and BermanBraun
  • NeuroFocus, Inc. in its sale to Nielsen Holdings, N.V.

Financing transactions

  • Greycroft Partners in various growth-equity investments, including Yeahka, a Chinese mobile payment service provider, and Performance Horizon Group Limited, a UK SaaS marketing platform
  • Thomvest Ventures in various investments, including in Apsalar, Avalanche Technology, Netbase and Tactus Technology.
  • IVP in its investment in Woven
  • Ayla Networks in its Series C preferred stock financing
  • WePay in its $40 million Series D preferred stock financing
  • ThredUp, Inc. in its $81 million Series E preferred stock financing
  • RocketLawyer in its preferred stock financings
  • Industry Ventures in is investment in TheRealReal
  • aTyr Pharma, Inc. in its $76 million Series E preferred stock financing
  • Royalty Pharma in its purchases of royalties in various transactions
  • TA Associates in its investment in Millennium Laboratories, Inc.
  • LLM Capital Partners in its investment in Hybrid Design Associates, LLC
  • Pipeline Angels in close to 20 portfolio investments
Professional Activities

Ms. Chang is a member of the American Bar Association, San Francisco Bar Association and the State Bar of California.

Professional Experience

Prior to joining Goodwin, Ms. Chang was a senior counsel at CBS Interactive Inc. (formerly CNET Networks, Inc.) from 2005-2008, where she advised and supported the company's Games, Music & Lifestyle and TV Entertainment divisions in their business-related matters as well as the company in its acquisitions, securities-related and other corporate matters. From 2002-2005, she was an associate in the corporate department of the San Francisco office of Latham & Watkins LLP.


While attending law school, Ms. Chang was a Notes and Comments Editor for The Tax Lawyer, for which she authored “Reasonableness, First Impression, and the Accuracy-Related Penalty: Neonatology Associates v. Commissioner” (2001).

In The News







J.D., 2002
Georgetown University Law Center
B.A., 1999
University of California, Berkeley

(magna cum laude, Phi Beta Kappa)



Get In Touch
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.


Search Other Lawyers